Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 23:19:1835.
doi: 10.3332/ecancer.2025.1835. eCollection 2025.

Challenges of osteosarcoma care in Africa: a scoping review of the burden, management and outcome

Affiliations
Review

Challenges of osteosarcoma care in Africa: a scoping review of the burden, management and outcome

Oluwaseun J Olajugba et al. Ecancermedicalscience. .

Abstract

Osteosarcoma has the highest incidence among individuals of African descent, with growing evidence suggesting ethnic and racial genetic underpinning. Hence, it presents a grave public health challenge in Africa given the widening inequities in access to cancer care. This scoping review addresses the critical gap in the availability of locally relevant data on the magnitude of the burden and challenges relating to the management and outcome of African centres. This study included 1,374 patients from eighteen studies. 81% presented with locally advanced or metastatic disease. While surgical treatment for osteosarcoma is shifting toward limb salvage on a global scale, amputation remains preponderant in Africa as only 53% underwent limb salvage operations. The pooled 5-year overall survival was 49.1%. Late presentation, workforce and infrastructural shortage, cultural beliefs, patronage of unorthodox medicine practitioners and high healthcare costs were the barriers driving poor outcomes in African centres. Strategies to improve outcomes should focus on addressing these barriers.

Keywords: Africa; SDG; oncology care inequity; osteosarcoma; public health.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1.
Figure 1.. PRISMA flowchart of article identification and selection process.
Figure 2.
Figure 2.. Map showing countries where the articles in this review originated and their income classification. LMIC: Lower middle-income country, UMIC: Upper middle-income country.

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Misaghi A, Goldin A, Awad M, et al. Osteosarcoma: a comprehensive review. SICOT J. 2018;4:12. doi: 10.1051/sicotj/2017028. - DOI - PMC - PubMed
    1. Cole S, Gianferante DM, Zhu B, et al. Osteosarcoma: a surveillance, epidemiology, and end results program-based analysis from 1975 to 2017. Cancer. 2022;128(11):2107–2118. doi: 10.1002/cncr.34163. - DOI - PMC - PubMed
    1. Sadykova LR, Ntekim AI, Muyangwa-Semenova M, et al. Epidemiology and risk factors of osteosarcoma. Cancer Invest. 2020;38(5):259–269. doi: 10.1080/07357907.2020.1768401. - DOI - PubMed
    1. Hamdi Y, Abdeljaoued-Tej I, Zatchi AA, et al. Cancer in Africa: the untold story. Front Oncol. 2021;11:650117. doi: 10.3389/fonc.2021.650117. - DOI - PMC - PubMed

LinkOut - more resources